This article discusses the use of tetracyclines in the clinical management of periodontal infections. A review of the drugs' pharmacology, pharmacokinetics, and potential adverse effects shows that they are relatively safe if used in appropriate dosages and under controlled conditions. Current data suggest that the routine use of tetracyclines in conjunction with the treatment of periodontitis is unnecessary. However, their distinctive characteristics can be utilized in different delivery systems as an adjunctive aid to conventional treatment of juvenile and refractory forms of periodontitis.
References
1.
Al-Joburi W., Chin Quee T., Lautar C., logovaz I., Bourgouin J., Delorme F., Chan ECS (1989). Effects of adjunctive treatment of periodontitis with tetracycline and spiramycin. J Periodontol60:533-539.
2.
Asikainen S., Alaluusua S., Saxen L. (1991). Recovery of A. actinomycetemcomitans from teeth, tongue, and saliva. J Periodontol62:203-206.
3.
Baker PI, Evans RT, Slots J., Genco RJ (1985). Antibiotic susceptibility of anaerobic bacteria from the human oral cavity. J Dent Res64:1233-1244.
4.
Birkedal-Hansen H. (1993). Role of matrix metalloproteinases in human periodontal diseases. I Periodontol64:474-484.
5.
Borden LC, Walker CB, Godowski KC (1996). Prevalence of doxycycline-resistant bacteria in an adult periodontitis population (abstract). J Dent Res75(Spec Iss):321.
6.
Borden LC, Walker CB, Stone C., Mankodi S., Godowski KC, Southard GL (1997). Microbiota effects following sustained release subgingival delivery of doxycycline (abstract). J Dent Res76(Spec Iss):153.
7.
Charpentier E., Gerbaud G., Courvalin P. (1993). Characterization of a new class of tetracycline-resistant gene tet(S) in Listeria monocytogenes BM4210. Gene131:27-34.
8.
Checchi L., Trombelli L., Nonato M. (1992). Postoperative infections and tetracycline prophylaxis in periodontal surgery: a retrospective study. Quintessence Int23:191-195.
9.
Chopra I. (1985). Mode of action of the tetracyclines and the nature of bacterial resistance to them. In: The tetracyclines. Hlavka JJ, Boothe JH, editors. Berlin: Springer-Verlag, pp. 317-322.
10.
Chopra I., Hawkey PM, Hinton M. (1992). Tetracyclines, molecular and clinical aspects. J Antimicrob Chem29:245-277.
11.
Christersson LA, Zambon JJ (1993). Suppression of subgingival Actinobacillus actinomycetemcomitans in localized juvenile periodontitis by systemic tetracycline. J Clin Periodontol20:395-401.
12.
Christersson LA, Zambon JJ, Wikesjo UME, Rosling BG, Dunford RG, Genco RJ (1986). The effects of systemic tetracycline alone on localized juvenile periodontitis (abstract). J Dent Res65(Spec Iss):805.
13.
Christersson LA, Norderyd OM, Puchalsky CS (1993). Topical application of tetracycline-HCl in human periodontitis. J Clin Periodontol20:88-95.
14.
Ciancio SG (1995). Nonsurgical chemical periodontal therapy. Periodontol20009:27-37.
15.
Ciancio SG, Mather ML, McMullen JA (1980). Evaluation of minocycline in patients with periodontal disease. J Periodontol51:530-534.
16.
Ciancio SG, Cobb CM, Leung M. (1992). Tissue concentration and localization of tetracycline following site-specific tetracycline fiber therapy. J Periodontol63:849-853.
17.
Crout RJ, Lee HM, Crout SH, Ramamurthy NS, Wiener M., Golub LM (1996). The "cyclic" regimen of low-dose doxycycline for adult periodontitis: A preliminary study. J Periodontol67:506-514.
18.
Demirel K., Baer PN, McNamara TF (1991). Topical application of doxycycline on periodontally involved root surfaces in vitro comparative analysis of substantivity on cementum and dentin. J Periodontol62:312-316.
19.
Drisko CL, Cobb CM, Killoy WJ, Michalowicz BS, Pihlstrom BL, Lowenguth RA, et al. (1995). Evaluation of periodontal treatments using controlled release tetracycline fibers: Clinical response. I Periodontol66:692-699.
20.
Eckles TA, Reinhardt RA, Dyer JK, Tussing G.), Szydlowski WM, DuBois LM (1990). Intracrevicular application of tetracycline in white petrolatum for the treatment of periodontal disease. J Clin Periodontol17:454-462.
21.
ElAttar TMA, Lin HS, Schultz R. (1988). Effect of minocycline on prostaglandin formation in gingival fibroblasts. J Periodont Res23:285-286.
22.
Fiehn NE, Westergaard J. (1990). Doxycycline-resistant bacteria in periodontally diseased individuals after systemic doxycycline therapy and in healthy individuals. Oral Microbiol Immunol5:219-222.
23.
Fiorellini JP, Paquette DW (1992). The potential role of controlled-release delivery systems for chemotherapeutic agents in periodontics. Curr Opin Dent2:63-79.
24.
Fletcher HM, Macrina FL (1991). Molecular survey of clindamycin and tetracycline resistance determinants in Bacteroides species. Antimicrob Agents Chemother35:2415-2418.
25.
Freeman EF, Ellen RP, Thompson G., Weinberg S., Song J., Lazarus RH (1992). Gingival crevicular fluid concentration and side effects of minocycline: A comparison of two dose regimens. J Periodontol63:13-18.
26.
Golub LM, Ramamurthy NS, McNamara TF, Gomes B., Wolff M., Casino A., et al. (1984). Tetracyclines inhibit tissue collagenase activity: A new mechanism in the treatment of periodontal disease. J Periodont Res19:651-655.
27.
Golub LM, Goodson JM, Lee HM, Vidal AM, McNamara TF, Ramamurthy NS (1985). Tetracyclines inhibit tissue collagenases. Effects of ingested low-dose and local delivery systems. J Periodontol56(Spec Iss):93-97.
28.
Golub LM, Ciancio S., Ramamurthy NS, Leung M., McNamara TF (1990). Low-dose doxycycline therapy: Effect on gingival and crevicular fluid collagenase activity in humans. J Periodont Res25:321-330.
29.
Golub LM, Ramamurthy NS, McNamara TF, Greenwald RA, Rifkin BR (1991). Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs. Crit Rev Oral Biol Med2:297-322.
30.
Golub LM, Wolff M., Roberts S., Lee HM, Leung M., Payonk GS (1994). Treating periodontal diseases by blocking tissue destructive enzymes. J Am Dent Assoc125:163-169.
31.
Golub LM, Sorsa T., Lee H.-M., Ciancio S., Sorbi D., Ramamurthy NS, et al. (1995). Doxycycline inhibits neutrophil (PMN)-type matrix metalloproteinases in human adult periodontitis gingiva. J Clin Periodontol22:100-109.
32.
Goodman LS, Gilman A, editors (1990). Tetracyclines. In: Goodman and Gilman's The pharmacological basis of therapeutics. New York: Pergamon Press, pp. 1117-1125.
33.
Goodson J., Tanner A. (1992). Antibiotic resistance of the subgingival microbiota following local tetracycline therapy. Oral Microbiol Immunol7:113-117.
34.
Goodson JM, Cugini MA, Kent RL, Armitage GC, Cobb CM, Fine D., et al. (1991a). Multi-centered evaluation of tetracycline fiber therapy: II. Clinical response. J Periodont Res26:371-379.
35.
Goodson JM, Tanner A., McArdle S., Dix K., Watanabe SM (1991b). Multi-centered evaluation of tetracycline fiber therapy: II. Microbiologic responses. J Periodont Res26:440-451.
36.
Gordon JM, Walker CB, Murphy JC, Goodson JM, Socransky SS (1981a). Concentrations of tetracycline in human gingival fluid after single doses. J Clin Periodontol8:117-121.
37.
Gordon JM, Walker CB, Murphy JC, Goodson JM, Socransky SS (1981b). Tetracycline: levels achievable in gingival crevice fluid and in vitro effect on subgingival organisms. Part I. Concentrations in crevicular fluid after repeated doses. J Periodontol52:609-611.
38.
Hansten PD, Horn JR ( 1985). Inhibition of oral contraceptive efficacy. Drug Interact Newsletter5:7-10.
39.
Hellden LB, Listgarten MA, Lindhe J. (1979). The effect of tetracycline and/or scaling on human periodontal disease. J Clin Periodontol6:222-230.
40.
Ingman T., Sorsa T., Suomalainen K., Halinen S., Lindy O., Lautio A., et al. (1993). Tetracycline inhibition identifies the cellular sources of collagenase in gingival crevicular fluid in different forms of periodontal diseases. J Periodontol64:82-88.
41.
Kastrup EK, editor (1993). Drug facts and comparisons. St. Louis: J.B. Lippincott Company, pp. 1811-1816.
42.
Kornman KS, Karl EH ( 1982). The effect of long-term low-dose tetracycline therapy on the subgingival microflora in refractory adult periodontitis. J Periodontol53:604-610.
43.
Kulkarni GV, Lee WK, Aitken S., Birek P., McCulloch CA (1991). A randomized, placebo-controlled trial of doxycycline: Effect on the microflora of recurrent periodontitis lesions in high risk patients. J Periodontol62:197-202.
44.
Lacroix JM, Walker CB (1995). Detection and incidence of the tetracycline resistance determinant tet(M) in the microflora associated with adult periodontitis. J Periodontol66:102-108.
45.
Larsen T. (1990). In vitro release of doxycycline from bioabsorbable materials and acrylic strips. J Periodontol61:30-34.
46.
Lee W., Aiken S., Kulkarni G., et al. (1991). Collagenase activity in recurrent periodontitis: relationship to disease progression and doxycycline therapy. ) J Periodont Res26:479-485.
47.
Lepper MH (1960). Communicable and infectious diseases. St. Louis: The C.V. Mosby Company, p. 137. Levy SB (1984). Resistance to the tetracyclines. In: Antimicrobial drug resistance. Bryan LE, editor. Orlando, FL: Academic Press, p. 191.
48.
Listgarten MA, Lindhe J., Hellden L. (1978). Effect of tetracycline and/or scaling on human periodontal disease. Clinical, microbiological, and histological observations. J Clin Periodontol5:246-271.
49.
MacAlpine R., Magnusson I., Kiger R., Crigger M., Garrett S., Egelberg J. (1985). Anti-microbial irrigation of deep pockets to supplemental hygiene instruction and root debridement. J Clin Periodontol12:568-577.
50.
Mandell RL, Socransky SS (1988). Microbiological and clinical effects of surgery plus doxycycline on juvenile periodontitis. J Periodontol59:373-378.
51.
Mandell RL; Tripodi LS, Savitt E., Goodson JM, Socransky SS (1986). The effect of treatment on Actinobacillus actinomycetemcomitans in localized juvenile periodontitis. J Periodontol57:94-99.
52.
Masters LB, Mellonig JT, Brunsvold MA, Nummikoski PV (1996). A clinical evaluation of demineralized freeze-dried bone allograft in combination with tetracycline in the treatment of periodontal osseous defects. J Periodontol67:770-781.
53.
McCulloch CA, Birek P., Overall C., Aitken S., Lee W., Kulkarni G. (1990). Randomized controlled trial of doxycycline in prevention of recurrent periodontitis in high-risk patients: Anti-microbial activity and collagenase inhibition. J Clin Periodontol17:616-622.
54.
McEvoy GK, editor (1997). Tetracyclines. In: American Hospital Formulary Service Drug Information. Vol. 8, No. 12.24. Bethesda, MD: American Society of Health-System Pharmacists, p. 378.
55.
Minabe M., Takeuchi K., Tamura T., Hori T., Umemoto T. (1989). Subgingival administration of tetracycline on a collagen film. J Periodontol60:552-556.
56.
Mombelli A. Schmid B., Lang NP ( 1997). Can P. gingivalis (Pg) and A. actinomycetemcomitans (Aa) be eradicated with local anti-microbial therapy? (abstract). I Dent Res76(Spec Iss):153.
57.
Müller HP, Lange DE, Müller RF (1993). Failure of adjunctive minocycline HCI to eliminate oral Actinobacillus actinomycetemcomitans. J Clin Periodontol20:498-504.
58.
Newman MG, Kornman KS, Doherty FM (1994). A 6-month multi-center evaluation of adjunctive tetracycline fiber therapy used in conjunction with scaling and root planing in maintenance patients: Clinical results. J Periodontol65:685-691.
59.
Novak MJ, Poison AM, Adair SM (1988). Tetracycline therapy in patients with early juvenile periodontitis. J Periodontol59:366-372.
60.
Novak MJ, Stamatelakys C., Adair SM (1991). Resolution of early lesions of juvenile periodontitis with tetracycline therapy alone: Long term observations of 4 cases. J Periodontol62:628-633.
61.
O'Connor BC, Newman HN, Wilson M. (1990). Susceptibility and resistance of plaque bacteria to minocycline. J Periodontol61:228-233.
62.
Olsvik B., Tenover FC (1993). Tetracycline resistance in periodontal pathogens. Clin Infect Dis16(Suppl 4):S310-S313.
63.
Olsvik B., Hansen BF, Tenover FC, Olsen I. (1995). Tetracycline-resistant micro-organisms recovered from patients with refractory periodontal disease. I Clin Periodontol22:391-396.
64.
Paquette D., Williams R., Offenbacher S., et at. (1997). Pharmacokinetic evaluation of a local delivery tetracycline hydrochloride gel in periodontitis patients (abstract). J Dent Res76(Spec Iss):.
65.
Parashis AO, Mitsis F.) (1992). Clinical evaluation of the effect of tetracycline root preparation on guided tissue regeneration in the treatment of class II furcation defects. J Periodontol64: 133-136.
66.
Pascale D., Gordon J., Lamster I., Mann P., Seiger M., Arndt W. (1986). Concentration of doxycycline in human gingival fluid. J Clin Periodontol13:841-844.
67.
Ramamurthy NS, Vernillo AT, Lee HM, Golub LM, Rifkin BR (1990). The effect of tetracyclines on collagenase activity in UMR 106-01 rat osteoblastic osteosarcoma cells. Res Commun Chem Pathol Pharmacol70:323-335.
68.
Rapley JW, Cobb CM, Killoy WJ, Williams DR (1992). Serum levels of tetracycline during treatment with tetracycline-containing fibers. J Periodontol63:817-820.
69.
Rasmussen BA, Gluzman Y., Tally FP (1994). Inhibition of protein synthesis occurring on tetracycline-resistant, tetM-protected ribosomes by a novel class of tetracyclines, the glycylcyclines. Antimicrob Agents Chemother38:1658-1660.
70.
Renvert S., Wikstrom M., Dahlen G., Slots J., Egelberg J. (1990). On the ability of root debridement and periodontal surgery to eliminate Aa from periodontal pockets. J Clin Periodontol17:351-355.
71.
Rifkin BR, Vernillo AT, Golub LM, Ramamurthy N. (1994). Modulation of bone resorption by tetracyclines. Ann NY Acad Sci6:165-180.
72.
Rompen EH, Kohl J., Nusgen B., Lapiere CM (1993). Kinetic aspects of gingival and periodontal ligament fibroblast attachment to surface-conditioned dentin. J Dent Res72:606-612.
73.
Salyers AA, Speer BS, Shoemaker NB (1990). New persepectives on tetracycline resistance. Mol Microbiol4:151-156.
74.
Sanz M., Serrano C., Garcia C., Echevarria C., O'Connor A. (1997). Clinical and microbiological efficacy of tetracycline fiber therapy in relapsing periodontal sites during supportive periodontal therapy (abstract). J Dent Res76(Spec Iss): 153.
75.
Saxen L., Asikainen S., Kanervo A., Kari K., Jousimies-Somer H. (1990). The long-term efficacy of systemic doxycycline medication in the treatment of localized juvenile periodontitis. Arch Oral Biol35:227S-229S.
76.
Scopp IW, Froum SJ, Sullivan M., Kazandjian G., Wank D., Fine A. ( 1980). Tetracycline: A clinical study to determine its effectiveness as long-term adjunct. I Periodontol51:328-330.
77.
Slots J., Rams TE ( 1990). Antibiotics in periodontal therapy: advantages and disadvantages. J Clin Periodontol17:479-493.
78.
Slots J., Rosling BG (1983). Suppression of the periodontopathic microflora in localized juvenile periodontitis by systemic tetracycline. J Clin Periodontol10:465-486.
79.
Somerman MJ, Foster RA, Vorsteg G., Progebin K., Wynn RL ( 1988). Effects of minocycline on fibroblast attachment and spreading. J Periodont Res23:154-159.
80.
Speer BS, Howemaker NB, Salyers AA (1992). Bacterial resistance to tetracycline: mechanisms, transfer, and clinical significance. Clin Micro Rev5:387-399.
81.
Stabholz A., Kettering J., Aprecio R., Zimmerman G., Baker PJ, Wikesjo UME (1993). Retention of anti-microbial activity by human root surfaces after in situ subgingival irrigation with tetracycline HCl or chlorhexidine. J Periodontol64:137-141.
82.
Sum PE, Lee VJ, Testa RT, et al. (1994). Glycylcyclines. 1. A new generation of potent antibacterial agents through modification of 9-aminotetracyclines. J Med Chem37:184-188.
83.
Tally FT, Ellestad GA, Testa RT (1995). Glycylcyclines: a new generation of tetracyclines. J Antimicrob Chemother35:449-452.
84.
Testa RR, Petersen PJ, Jacobus NV, Sum PE, Lee VJ, Tally FP ( 1993). In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines. Antimicrob Agents Chemother37:2270-2277.
85.
Thomas J., Crout RJ, Crout RM, Cook D., Keating G., Wearden CS, et al. (1995). Antibiotic resistance evaluation with low-dose doxycycline (LDD) in adult periodontitis (abstract). J Dent Res74 (Spec Iss):575.
86.
Tonetti M., Cugini MA, Goodson JM (1990). Zero-order delivery with periodontal placement of tetracycline-loaded ethylene vinyl acetate fibers. J Periodont Res25:243-249.
87.
United States Pharmacopeia Drug Information ( 1992). Drug information for the health care provider. Rockville, MD: United States Pharmacopeia Convention, pp. 2603-2614.
88.
van Steenberghe D., Bercy P., Kohl J., De Boever J., Adriaens P., Vanderfacile A., et al. (1993). Subgingival minocycline hydrochloride ointment in moderate to severe chronic adult periodontitis: A randomized, double-blind, vehicle-controlled, multicenter study. J Periodontol64:637-644.
89.
Vernillo AT, Ramamurthy NS, Golub LM, Rifkin BR (1994). The non-antimicrobial properties of tetracycline for the treatment of periodontal disease. Curr Opin Periodontol: 111-118.
90.
Walker CB (1996). The acquisition of antibiotic resistance in the periodontal microflora. Periodontol200010:79-88.
91.
Walker CB, Pappas JD, Tyler KZ, Cohen S., Gordon JM (1985). Antibiotic susceptibilities of periodontal bacteria. In vitro susceptibilities to eight antimicrobial agents. J Periodontol56(Suppl):67-74.
92.
Williams BL, Osterberg SKA, Jorgensen J. (1979). Subgingival microflora of periodontal patients on tetracycline therapy. J Clin Periodontol6:210-221.
93.
Yanagimura M., Koike F., Hara K. ( 1989). Collagenase activity in gingival crevicular fluid and inhibition by tetracyclines. J Dent Res68(Spec Iss):1691-1693.
94.
Yukna RA, Sepe WW ( 1982). Clinical evaluation of localized periodontitis defects treated with freeze-dried bone allografts combined with local and systemic tetracycline. Int J Perio Rest2(5):9-21.
